GI Partners-backed Clinical Ink taps Goldman as CEO

Goldman succeeds Ed Seguine who has led Clinical Ink since nearly fourteen years ago.

13 February 2023•2 mins read
LinkedInXEmail
LinkedInXEmail

Related articles